Newsfeeds - Spark Newswire

2 minute read

Selecta Biosciences Announces Appointment Of Kevin Tan As Chief Financial Officer

Today, 10:52 AM

Selecta Biosciences, Inc. (NASDAQ:SELB), a biotechnology company leveraging its clinically validated ImmTOR™ platform to develop tolerogenic therapies that selectively mitigate unwanted immune responses, today

SELB

6 minute read

77 Biggest Movers From Yesterday

By Lisa Levin

Today, 10:52 AM

Gainers Powerbridge Technologies Co., Ltd. (NASDAQ: PBTS) shares surged 65.4% to close at $2.10 on Thursday after the company announced it is expanding its blockchain business to engage in cryptocurrency mining.

ABVC

1 minute read

Selecta Biosciences Q2 EPS $0.00, Sales $19.66M Beat $6.24M Estimate

By Bill Haddad

Today, 10:52 AM

Selecta Biosciences (NASDAQ:SELB) reported quarterly sales of $19.66 million which beat the analyst consensus estimate of $6.24 million by 215.11 percent.

SELB

1 minute read

Selecta Biosciences: Q2 Earnings Insights

By Benzinga Insights

Today, 10:52 AM

Shares of Selecta Biosciences (NASDAQ:SELB) were unchanged after the company reported Q2 results. Quarterly Results Earnings per share were up 100.00% over the past year to $0.00, which beat the estimate of ($0.12).

SELB

5 minute read

The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma

By Shanthi Rexaline

Today, 10:52 AM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 11)

ABCL

15 minute read

Earnings Scheduled For August 12, 2021

By Benzinga Insights

Today, 10:52 AM

Companies Reporting Before The Bell • Anavex Life Sciences (NASDAQ:AVXL) is estimated to report earnings for its third quarter.

AACG

7 minute read

The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight

By Shanthi Rexaline

Today, 10:52 AM

Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in, triggering stock-specific moves, while clinical readouts also moved stocks during the week.

ABCL